Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2024 Quest Diagnostics Incorporated. All rights reserved.
The first study to obtain a detailed profile of users of synthetic cannabinoids was published in the May 20 issue of CESAR (Center for Substance Abuse Research) report.
According to this research, synthetic cannabinoid use among college students at a Southeastern university is concentrated in males and in the lesbian, gay, bisexual or transgender (LGBT) community. Students who self-identified themselves as LGBT were nearly twice as likely as heterosexual students (27 percent vs. 14 percent) to report lifetime use.
The study also found that lifetime use of synthetic cannabinoids was virtually non-existent among those who did not report past month alcohol (0.3 percent) or marijuana (0.4 percent) use, compared to 16 percent and 24 percent, respectively, of past month users of these substances.
View a PDF of the complete CESAR report.
For more information about drug testing, visit our website.